These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 301573)

  • 1. A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens.
    Minowada J; Tsubota T; Greaves MF; Walters TR
    J Natl Cancer Inst; 1977 Jul; 59(1):83-7. PubMed ID: 301573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic study of a new Ph1-positive cell line (NALM-1).
    Sonta SI; Minowada J; Tsubota T; Sandberg AA
    J Natl Cancer Inst; 1977 Sep; 59(3):833-7. PubMed ID: 302341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabbit antiserum against a non-T, non-B leukemia cell line that carries the Ph1 chromosome (NALM-1): antibody specific to a non-T, non-B acute lymphoblastic leukemia antigen.
    Koshiba H; Minowada J; Pressman D
    J Natl Cancer Inst; 1978 Oct; 61(4):987-91. PubMed ID: 81309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane marker analysis of 'lymphoid' and myeloid blast crisis in PH1 positive (chronic myeloid) leukemia.
    Janossy G; Greaves MF; Capellaro D; Roberts M; Goldstone AH
    Haematol Blood Transfus; 1977; 20():97-107. PubMed ID: 305406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of thymus-derived lymphocyte markers in myelogenous leukemia (Ph1+) cell line K-562.
    Lozzio CB; Lozzio BB; Yang WK; Ichiki AT; Bamberger EG
    Cancer Res; 1976 Dec; 36(12):4657-62. PubMed ID: 63324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heteroantiserum against acute lymphocytic leukemia raised to the lymphoblastoid cell line NALM-1.
    Billing R; Clark B; Guidera K; Minowada J
    Int J Cancer; 1978 Dec; 22(6):694-9. PubMed ID: 309868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target cell in chronic myeloid leukaemia and its relationship to acute lymphoid leukaemia.
    Janossy G; Roberts M; Greaves MF
    Lancet; 1976 Nov; 2(7994):1058-61. PubMed ID: 62904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a unique cell line (LAZ 221) from human acute lymphocytic ("null" cell) leukemia.
    Lazarus H; Barell EF; Krishan A; Livingston DM; Harris K; Schlossman SF; Chess L
    Cancer Res; 1978 May; 38(5):1362-7. PubMed ID: 205365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
    Baryshnikov AIu
    Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terminal deoxynucleotidyl transferase activity and cell surface antigens of two unique cell lines (NALM-1 and BALM-2) of human leukemic origin.
    Sahai Srivastava BI; Minowada J
    Int J Cancer; 1977 Aug; 20(2):199-205. PubMed ID: 70413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological characterization of normal and leukemia-associated antigens of acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis.
    Mohanakumar T; Miller DS; Anderson J; Metzgar RS
    Cancer Res; 1978 Mar; 38(3):716-22. PubMed ID: 75058
    [No Abstract]   [Full Text] [Related]  

  • 12. Recognition by human and rabbit sera of common antigens to leukemia blast cells, peripheral blood B-lymphocytes, and monocytes.
    Zighelboim J; Bick A; Durantez A
    Cancer Res; 1977 Oct; 37(10):3656-62. PubMed ID: 71197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a Ph1-positive human cell line (BV173).
    Pegoraro L; Matera L; Ritz J; Levis A; Palumbo A; Biagini G
    J Natl Cancer Inst; 1983 Mar; 70(3):447-53. PubMed ID: 6572735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a common acute lymphoblastic leukemia cell line (LC4-1) and effects of phorbol myristate acetate (PMA) on the surface antigen expression of the cell line.
    Yoshimura T; Mayumi M; Yorifuji T; Kim KM; Heike T; Miyanomae T; Shinomiya K; Mikawa H
    Am J Hematol; 1987 Sep; 26(1):47-54. PubMed ID: 3115091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
    Negoro S; Seon BK
    Cancer Res; 1981 Jul; 41(7):2973-6. PubMed ID: 6972802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of T lymphocytes in the spleen in chronic granulocytic leukaemia.
    Kaur J; Catovsky D; Spiers AS; Galton DA
    Lancet; 1974 May; 1(7862):834-6. PubMed ID: 4132790
    [No Abstract]   [Full Text] [Related]  

  • 17. Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia.
    Klein E; Ben-Bassat H; Neumann H; Ralph P; Zeuthen J; Polliack A; Vánky F
    Int J Cancer; 1976 Oct; 18(4):421-31. PubMed ID: 789258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. I. Detection by rabbit antisera.
    Billing R; Rafizadeh B; Drew I; Hartman G; Gale R; Terasaki P
    J Exp Med; 1976 Jul; 144(1):167-78. PubMed ID: 778323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of cultured leukemic cell lines monitored by chromosomal and immunologic analysis.
    Hozier J; Lindquist L; Hurwitz R; LeBien T; Kersey J
    Int J Cancer; 1980 Sep; 26(3):281-4. PubMed ID: 6945291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
    Han T; Gomez GA; Minowada J
    Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.